Dysthyroid optic neuropathy: evaluation and management

被引:65
|
作者
Dolman, P. J. [1 ]
机构
[1] Univ British Columbia, Vancouver Gen Hosp, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada
关键词
Thyroid eye disease; Graves orbitopathy; Dysthyroid optic neuropathy; Compressive optic neuropathy; Stretch optic neuropathy; Orbital decompression; GRAVES ORBITOPATHY EUGOGO; QUALITY-OF-LIFE; ORBITAL RADIOTHERAPY; EUROPEAN GROUP; TED-QOL; OPHTHALMOPATHY; DISEASE; RISK; QUESTIONNAIRE; DECOMPRESSION;
D O I
10.1007/s40618-020-01361-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Dysthyroid optic neuropathy (DON) is a serious complication of Graves orbitopathy (GO) from optic nerve dysfunction that may result in permanent loss of vision. Purpose This paper reviews the current knowledge of DON, including its pathogenesis and epidemiology, clinical and radiologic features, and management choices and outcomes. Methods Literature review and author retrospective case series. Results Over 90% of DON cases are related to nerve compression by enlarged extraocular muscles (EOM) while the remainder are caused by stretching of the optic nerve without compression. DON's incidence is 5-8% of GO cases. Risk factors include advancing age, male gender, smoking and diabetes mellitus, and these cases should be referred promptly to an ophthalmologist or GO clinic to rule out DON and for ongoing care. Clinical features of DON may include reduction in central and colour vision (unexplained by other ocular disorders), afferent pupil defect and/or optic disc edema. Since most cases are associated with enlarged EOM, restricted motility and soft tissue venous congestion are common. Visual fields and optical coherence tomography (OCT) help confirm the diagnosis while CT or MRI Scans show apical optic nerve compression or proptosis with optic nerve stretch. Standard therapy includes iv/oral corticosteroids (CS) with partial response in most cases, but often relapse with tapering. Radiotherapy may delay or avoid surgery and may prevent the onset of DON when combined with CS in high-risk individuals. The benefits of newer biologic targeted therapy are not clear. Orbital decompression surgery often has positive outcomes, even in cases of severe vision loss or delayed surgery. The most common surgical complication is worsening strabismus, which may worsen visual function and quality of life. In rare cases, permanent vision loss from DON may occur despite full therapy. Conclusions Although DON may cause vision loss, most cases are reversible if recognized and managed in a timely manner.
引用
收藏
页码:421 / 429
页数:9
相关论文
共 50 条
  • [41] Acute Dysthyroid Optic Neuropathy Exacerbated by Orbital Radiotherapy
    Hersh, Dov
    Kinnar, Merchant
    ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2014, 33 (05): : 385 - 387
  • [42] Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery
    Sandra Rezar-Dreindl
    Andrea Papp
    Arnulf Baumann
    Thomas Neumayer
    Katharina Eibenberger
    Eva Stifter
    Ursula Schmidt-Erfurth
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 3683 - 3691
  • [43] Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery
    Rezar-Dreindl, Sandra
    Papp, Andrea
    Baumann, Arnulf
    Neumayer, Thomas
    Eibenberger, Katharina
    Stifter, Eva
    Schmidt-Erfurth, Ursula
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (11) : 3683 - 3691
  • [44] Ultrasonographic measurement of the optic nerve sheath diameter in dysthyroid optic neuropathy
    Xian Ji
    Wei Xiao
    Huijing Ye
    Rongxin Chen
    Jinghong Wu
    Yuxiang Mao
    Huasheng Yang
    Eye, 2021, 35 : 568 - 574
  • [45] Teprotumumab for Dysthyroid Optic Neuropathy: Early Response to Therapy
    Sears, Connie M.
    Azad, Amee D.
    Dosiou, Chrysoula
    Kossler, Andrea L.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2021, 37 (3S): : S157 - S160
  • [46] A RETROSPECTIVE REVIEW OF 26 CASES OF DYSTHYROID OPTIC NEUROPATHY
    PANZO, GJ
    TOMSAK, RL
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1983, 96 (02) : 190 - 194
  • [47] DYSTHYROID OPTIC NEUROPATHY - THE CROWDED ORBITAL APEX SYNDROME
    NEIGEL, JM
    ROOTMAN, J
    BELKIN, RI
    NUGENT, RA
    DRANCE, SM
    BEATTIE, CW
    SPINELLI, JA
    OPHTHALMOLOGY, 1988, 95 (11) : 1515 - 1521
  • [48] Rapamycin for treatment of refractory dysthyroid compressive optic neuropathy
    Chang, Susie
    Perry, Julian D.
    Kosmorsky, Gregory S.
    Braun, William E.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2007, 23 (03): : 225 - 226
  • [49] Optic Nerve Stretch Is Unlikely to Be a Significant Causative Factor in Dysthyroid Optic Neuropathy
    Rose, Geoffrey E.
    Vahdani, Kaveh
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2020, 36 (02): : 157 - 163
  • [50] Pterional Orbit Decompression in Grave Disease with Dysthyroid Optic Neuropathy
    Kuechlin, Sebastian
    Steiert, Christine
    Naseri, Yashar
    Joachimsen, Lutz
    Gruber, Markus
    Reich, Michael
    Boehringer, Daniel
    Metzger, Mark
    Beck, Juergen
    Scheiwe, Christian
    Lagreze, Wolf A.
    Grauvogel, Juergen
    WORLD NEUROSURGERY, 2021, 149 : E1007 - E1016